Nutex Health, Inc. (NUTX) has a consensus analyst rating of Buy, based on 2 analysts covering the stock. Of those, 2 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for NUTX is $205.00, representing a +90.1% upside from the current price of $107.84. Price targets range from a low of $205.00 to a high of $205.00.
